The Ohio State University Dermatology Biorepository

RECRUITING

I'm interested ...!!

This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.

Conditions:

Hidradenitis Suppurativa

Study Start (Actual) 2017-04-19

Primary Completion (Estimated) 2030-12-31

Study Completion (Estimated) 2030-12-31

Enrollment (Estimated) 175

Study Type OBSERVATIONAL

Phase N/A

Locations:

📍 Columbus, Ohio, United States

Eligibility Criteria

Description

Inclusion Criteria:

* Seen by an Ohio State University (OSU) Dermatology provider on the main University Hospital campus, including the James Cancer Hospital, OSU Dermatology East, OSU Dermatology at the Ohio State Eye and Ear Institute, Martha Morehouse Medical Pavilion, and OSU Dermatology at Upper Arlington after the date of approval of this protocol
* Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals
* Willingness to participate in a research study.

Exclusion Criteria:

* Inability to provide informed consent

Ages Eligible for Study: N/A to N/A (CHILD, ADULT, OLDER_ADULT)

Sexes Eligible for Study: ALL

Accepts Healthy Volunteers: Yes

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted2017-05-05
First Submitted that Met QC Criteria2017-05-09
First Posted2017-05-10

Study Record Updates

Last Update Submitted that Met QC Criteria2024-04-02
Last Update Posted2024-04-03
Last Verified2024-04